GP531 adenosine regulating agent: GNSA began a pilot Phase II trial

Gensia Inc. (GNSA), San Diego, Calif. Product: GP531 adenosine regulating agent Indication: Angioplasty Status: GNSA began a pilot Phase II trial of GP531 to evaluate the effects of the second-genera...